アンチセンス及びRNAi治療の世界市場...市場調査レポートについてご紹介

【英文タイトル】Global Antisense and RNAi Therapeutics Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07.Market Segmentation by Technology

08.Market Segmentation by Therapeutics Area

09.Geographical Segmentation
09.1 Antisense and RNAi Therapeutics Market in Americas
09.1.1 Market Size and Forecast
09.2 Antisense and RNAi Therapeutics Market in EMEA Region
09.2.1 Market Size and Forecast
09.3 Antisense and RNAi Therapeutics Market in APAC Region
09.3.1 Market Size and Forecast

10.Buying Criteria

11.Pipeline Snapshot

12.Market Growth Drivers

13.Drivers and their Impact

14.Market Challenges

15.Impact of Drivers and Challenges

16.Market Trends

17.Trends and their Impact

18.Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions and Collaborations
18.2 Vendor Analysis 2014
18.3 Other Prominent Vendors

19.Key Vendor Analysis
19.1 Alnylam Pharmaceuticals
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Financial Performance
19.1.4 Recent Developments
19.1.5 SWOT Analysis
19.2 Isis Pharmaceuticals
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Revenue Comparison 2011 and 2013
19.2.4 Recent Developments
19.2.5 SWOT Analysis
19.3 Sanofi SA
19.3.1 Key Facts
19.3.2 Business Description
19.3.3 Business Segmentation
19.3.4 Revenue by Business Segmentation
19.3.5 Revenue Comparison 2012 and 2013
19.3.6 Sales by Geography
19.3.7 Business Strategy
19.3.8 Key Developments
19.3.9 SWOT Analysis
19.4 Tekmira Pharmaceuticals
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Financial Performance
19.4.4 Key Developments
19.4.5 SWOT Analysis

20.Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Antisense and RNAi Therapeutics Market 2014-2019 (US$ million)
Exhibit 3: Global Antisense and RNAi Therapeutics Market Segmentation by Technology
Exhibit 4: Global Antisense and RNAi Therapeutics Market Segmentation by Technology 2014
Exhibit 5: Global Antisense and RNAi Therapeutics Market by Therapeutics Area
Exhibit 6: Global Antisense and RNAi Therapeutics Market by Geographical Segmentation 2014
Exhibit 7: Antisense and RNAi Therapeutics Market in Americas 2014-2019 (US$ million)
Exhibit 8: Antisense and RNAi Therapeutics Market in EMEA Region 2014-2019 (US$ million)
Exhibit 9: Antisense and RNAi Therapeutics Market in APAC Region 2014-2019 (US$ million)
Exhibit 10: Global Antisense and RNAi Therapeutics Market by Geographical Segmentation 2014-2019 (US$ million)
Exhibit 11: Global Antisense and RNAi Therapeutics Market by Geographical Segmentation 2014-2019
Exhibit 12: Alnylam Pharmaceuticals: Financial Performance 2013-2012 (in million)
Exhibit 13: Isis Pharmaceuticals: Revenue Comparison 2011 and 2013(US$ million)
Exhibit 14: Sanofi SA: Business Segmentation
Exhibit 15: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 16: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 17: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
Exhibit 18: Tekmira Pharmaceuticals: Financial Performance 2012-2013


【レポート販売概要】

■ タイトル:アンチセンス及びRNAi治療の世界市場
■ 英文:Global Antisense and RNAi Therapeutics Market 2015-2019
■ 発行日:2014年11月12日
■ 調査会社:Technavio
■ 商品コード:IRTNTR4600
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。